Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Plasma cell 1Gynecologic 1

Conditions

Rectal Neoplasms 45Colorectal Neoplasms 45Esophageal Neoplasms 28Esophageal Squamous Cell Carcinoma 24Stomach Neoplasms 22Pancreatic Neoplasms 19Colonic Neoplasms 18Adenocarcinoma Of Esophagus 15Carcinoma, Hepatocellular 14Neoplasm Metastasis 7Liver Neoplasms 6Cholangiocarcinoma 5Recurrence 4Locally Advanced Rectal Cancer 4Turcot syndrome 3Peritoneal Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Breast Neoplasms 2Bites and Stings 2Adenocarcinoma 2Surgery 1Successful Conversion Rate of Operation 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Pathologic Complete Response 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Ductal Adenocarcinoma 1

Interventions

Oxaliplatin 10Gemcitabine 8Cisplatin 7Hepatectomy 6Fluorouracil 6Radiofrequency Ablation 5Liver Transplantation 5Irinotecan 5Capecitabine 5lenvatinib 4Paclitaxel 4Neoadjuvant Therapy 4Folfox protocol 4Cetuximab 4Aspirin 4tislelizumab 3Surgical Procedures, Operative 3Nivolumab 3Carboplatin 3titanium silicide 2durvalumab 2apatinib 2Trastuzumab 2S 1 (combination) 2Leucovorin 2Lamivudine 2Introns 2Ethiodized Oil 2Drug Therapy 2DNA, Mitochondrial 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recurrence × Neoadjuvant Therapy × Gastrointestinal × Clear all
NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
600 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

NCT05861505 2023-05-17

COLLISION RELAPSE Trial

Amsterdam UMC, location VUmc

Phase 3 Recruiting
360 enrolled
Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT03899870 2019-04-02

Factors Predicting Recurrence in Rectal Cancer After Surgery

Université de Sousse

Completed
188 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Seoul National University Hospital

Phase 2/3 Completed
58 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡